Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| VBIO | 8-K | bearish | 7/10 | Valion Bio (VBIO) filed an 8-K detailing a complex capital restructuring: CEO Michael Handley was terminated, Lisa Wolf | Aug 17, 2026 |
| CNC | 8-K | neutral | 3/10 | Centene announced a planned CFO transition: current CFO Drew Asher will retire effective December 31, 2026, and remain a | Aug 17, 2026 |
| PROP | 8-K | bearish | 7/10 | Prairie Operating Co. entered into a Third Amendment to its credit agreement that significantly relaxes its current rati | Aug 17, 2026 |
| ULTA | 8-K | neutral | 2/10 | Ulta Beauty appointed Brieane L. Olson, CEO of PacSun, as an independent director effective August 31, 2026, filling the | Aug 17, 2026 |
| MOS | 8-K | bullish | 5/10 | Mosaic completed a cash tender offer to repurchase $870.986 million aggregate principal amount of its outstanding debt s | Aug 17, 2026 |
| PPTA | 8-K | neutral | 2/10 | Perpetua Resources filed an 8-K on August 17, 2026, solely to disclose the publication of an updated investor presentati | Aug 17, 2026 |
| ACH | 8-K | bullish | 5/10 | Accendra Health filed an 8-K to announce it will not implement an ATM equity program (positive for existing shareholders | Aug 17, 2026 |
| ADIL | 8-K | bullish | 7/10 | Adial Pharmaceuticals reported Q2 2026 results highlighting a strategic pivot via the acquisition of Azora Therapeutics | Aug 17, 2026 |
| CSAI | 8-K | mixed | 6/10 | Cloudastructure reported Q2 2026 revenue of $1.2M (+13% YoY) and a narrowed net loss of ~$1.7M, driven by a 164% surge i | Aug 17, 2026 |
| NSPR | 8-K | bearish | 6/10 | InspireMD's Q2 2026 revenue was essentially flat YoY at $1.77M, missing the $2.1M consensus estimate due to a voluntary | Aug 17, 2026 |
| MAIR | 8-K | bullish | 8/10 | Madison Air Solutions (MAIR) has entered into a definitive agreement to acquire ebm-papst, a German leader in high-perfo | Aug 17, 2026 |
| ENVX | 8-K | neutral | 6/10 | Enovix CEO Raj Talluri resigned abruptly on August 13, 2026; T.J. Rodgers (non-executive chairman and largest shareholde | Aug 17, 2026 |
| PROP | 8-K | bearish | 7/10 | Prairie Operating Co. reported Q2 2026 revenue of $98.9 million, up ~45% YoY, and GAAP net income attributable to common | Aug 17, 2026 |
| ACHV | 8-K | bearish | 5/10 | Achieve Life Sciences entered into an Open Market Sale Agreement with Jefferies LLC to establish an at-the-market (ATM) | Aug 14, 2026 |
| ZNTL | 8-K | bearish | 6/10 | Zentalis Pharmaceuticals priced a public offering of 23,000,000 shares of common stock at $3.50 per share, with an under | Aug 14, 2026 |
| FEMY | 8-K | bearish | 6/10 | Femasys reported Q2 2026 revenue of $331,827 (down 18.9% YoY) and a net loss of $4,469,095 ($-1.33/share), with no conse | Aug 14, 2026 |
| BNAI | 8-K | neutral | 5/10 | Brand Engagement Network Inc. filed its Q2 2026 10-Q and issued a press release focused on the transformative June 30, 2 | Aug 14, 2026 |
| RVP | 8-K | bearish | 6/10 | Retractable Technologies reported Q2 2026 net sales of $7.2M, down 30.8% YoY from $10.4M, with an operating loss of $5.1 | Aug 14, 2026 |
| CTVA | 8-K | neutral | 4/10 | Corteva disclosed that its subsidiary Vylor, Inc. filed the first amendment to its Form 10 registration statement with t | Aug 14, 2026 |
| UP | 8-K | neutral | 3/10 | Wheels Up Experience Inc. disclosed the departure of Chief Sales Officer Mark Briffa under a settlement agreement that p | Aug 14, 2026 |
| IHT | 8-K | mixed | 5/10 | IHT filed an 8-K reporting routine shareholder meeting results (trustee re-elected, auditor ratified) and disclosed reco | Aug 14, 2026 |
| OCLT | 8-K | neutral | 4/10 | OceanLight Acquisition Corp filed an 8-K reporting the consummation of its $100M IPO on August 10, 2026, selling 10M uni | Aug 14, 2026 |
| AUID | 8-K | bearish | 7/10 | authID reported Q2 2026 results and announced its Board is evaluating strategic and financing alternatives, including a | Aug 14, 2026 |
| ISPC | 8-K | bearish | 7/10 | iSpecimen Inc. (ISPC) entered into a $2,000,000 cash consulting agreement with IR Agency LLC for marketing and advertisi | Aug 14, 2026 |
| BAYA | 8-K | neutral | 3/10 | Bayview Acquisition Corp (BAYA), a SPAC, deposited $50,000 into its trust account to extend its deadline to complete a b | Aug 14, 2026 |
| BYSI | 8-K | neutral | 4/10 | BeyondSpring reported Q2 2026 financial results with a net loss from continuing operations of $1.8M, roughly in line wit | Aug 14, 2026 |
| SIDU | 8-K | mixed | 6/10 | Sidus Space reported Q2 2026 revenue of $583,000, a 54% decline YoY from $1.3M, driven by the timing of fixed-price mile | Aug 14, 2026 |
| CNTN | 8-K | mixed | 5/10 | Canton Strategic Holdings reported its first-ever operating revenue of $1.5M for Q2 2026, transitioning from zero revenu | Aug 14, 2026 |
| MLM | 8-K | neutral | 5/10 | Martin Marietta issued $5.5 billion in senior unsecured notes across five tranches (4.850% due 2029, 5.200% due 2032, 5. | Aug 14, 2026 |
| VYCO | 8-K | bearish | 6/10 | Vycor Medical reported Q2 2026 revenue of $418,264, a 16% decline YoY, driven by a 17% drop in the core VBAS division's | Aug 14, 2026 |